Clinical Trial Update: Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating low-dose nesiritide with or without sildenafil in patients with heart failure and renal dysfunction was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Dysfunction

Drugs mentioned

• Natrecor (nesiritide)
• Viagra (Sildenafil)

Snippet

Sponsor: Mayo Clinic | Conditions: Congestive Heart Failure, Renal Dysfunction | Phase 1 | Status: TERMINATED